List of insiders holdings for Foghorn Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Flagship Ventures Fund V General Partner LLC Flagship Ventures Opportunities Fund I General Partner LLC Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Ventures Fund V L.P. Flagship Ventures Opportunities Fund I L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner | 2024-05-24 17:00:59 | 16,303,949 0 | 16,303,949 | Form 13D |
| KADOCH CIGALL Director | 2022-09-02 08:07:29 | 323,530 3,329,379 | 3,652,909 | Form 4 |
| Flagship Pioneering Inc. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Special Opportunities Fund II L.P. AFEYAN NOUBAR 10% Owner | 2024-05-24 17:05:08 | 0 3,629,829 | 3,629,829 | Form 4 |
| Flagship Pioneering Fund VII General Partner LLC Flagship Pioneering Fund VII L.P. 10% Owner | 2024-05-24 17:00:10 | 0 1,814,915 | 1,814,915 | Form 3 |
| Abu Dhabi Investment Authority Platinum International Investment Holding RSC Ltd Platinum Falcon B 2018 RSC Ltd Former 10% Owner | 2020-10-28 06:02:15 | 1,231,081 0 | 1,231,081 | Form 4 |
| Reine Allan Chief Financial Officer | 2024-01-17 16:01:54 | 748,188 0 | 748,188 | Form 4 |
| DECICCO CARL Chief Scientific Officer | 2021-12-13 20:37:39 | 583,551 0 | 583,551 | Form 4 |
| Cavalie Fanny Chief Strategy/Bus Ops Officer | 2024-06-24 16:01:17 | 482,161 0 | 482,161 | Form 4 |
| Agresta Samuel Chief Medical Officer | 2023-09-13 16:02:28 | 376,891 0 | 376,891 | Form 4 |
| GOTTSCHALK ADRIAN Chief Executive Officer | 2024-01-25 16:05:59 | 300,000 0 | 300,000 | Form 4 |
| Humer Kristian Chief Financial Officer | 2024-04-17 16:01:57 | 275,000 0 | 275,000 | Form 4 |
| Rivkin Anna Chief Business Officer | 2024-09-04 16:02:47 | 190,000 0 | 190,000 | Form 4 |
| Bellon Steven F. Chief Scientific Officer | 2024-09-11 16:00:27 | 101,957 0 | 101,957 | Form 4 |
| LaCascia Michael Chief Legal Officer | 2024-01-25 16:01:40 | 100,000 0 | 100,000 | Form 4 |
| Baselga Jose Director | 2020-10-22 20:56:11 | 94,594 0 | 94,594 | Form 3 |
| Costa Carlos Chief People Officer | 2024-09-24 16:01:55 | 80,435 0 | 80,435 | Form 4 |
| Cardama Alfonso Quintas Chief Medical Officer | 2024-01-25 16:04:15 | 60,000 0 | 60,000 | Form 4 |
| Cole Douglas G. Director | 2024-06-28 16:03:47 | 16,000 0 | 16,000 | Form 4 |
| GILL SIMBA Director | 2024-06-28 16:04:41 | 16,000 0 | 16,000 | Form 4 |
| Lynch Thomas J. Jr. Director | 2024-06-28 16:06:10 | 16,000 0 | 16,000 | Form 4 |
| SMITH IAN F Director | 2024-06-28 16:06:35 | 16,000 0 | 16,000 | Form 4 |
| Mendelsohn Michael Director | 2024-06-28 16:07:38 | 16,000 0 | 16,000 | Form 4 |
| Biller Scott Director | 2024-06-28 16:08:04 | 16,000 0 | 16,000 | Form 4 |
| PARSHALL B LYNNE Director | 2024-06-28 16:02:16 | 16,000 0 | 16,000 | Form 4 |
| Koppel Adam Director | 2024-06-28 16:00:47 | 16,000 0 | 16,000 | Form 4 |